Those with the MPO GG variation were expected to have the greater ability to upregulate oxidative stress while those with GA/AA variants were compromised, i.e., with a 2-fold increase in aggressive prostate cancer risk among men with low n-3 LC-PUFA. This evidence concerns the gene MPO and Familial prostate cancer.